Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Interventional Non-randomized and Non-comparative Series of Cases of Patiens Suffering Ocular Surface Syndrome Post-LASIK: Outcomes After the Treatment With Platelet Rich Plasma

NCT03322917 is registered in ClinicalTrials.gov with Vissum, Instituto Oftalmológico de Alicante as lead sponsor.

NCT NCT03322917
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03322917 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Interventional Non-randomized and Non-comparative Series of Cases of Patiens Suffering Ocular Surface Syndrome Post-LASIK: Outcomes After the Treatment With Platelet Rich Plasma
Lead sponsor
Vissum, Instituto Oftalmológico de Alicante
Phase
Phase 2
Overall status
Completed
Start date
July 1, 2008
Completion date
January 17, 2013
Enrollment
80 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye after lasik-laser in situ keratomileusis